ClinConnect ClinConnect Logo
Search / Trial NCT06339294

Efficacy of Pyodine Soaked Gelfoam vs Single Topical Application of Clotrimazole in Otomycosis Treatment

Launched by RAWALPINDI MEDICAL COLLEGE · Mar 24, 2024

Trial Information

Current as of July 22, 2025

Completed

Keywords

Otomycosis Clotrimazole Ointment Povidone Iodine

ClinConnect Summary

INTRODUCTION:

Otomycosis, external auditory canal fungal infection is a recurrent and prevalent condition affecting 9%to 27.2% of patients worldwide. Use of topical antibiotics, humid conditions, and trauma to the external auditory canal are well-recognized risk factors for this disease. Aspergillus nigar (60-90%), and Candida species (10-40%) are the most commonly isolated pathogens in patients with otomycosis. Otomycosis presents with bothersome symptoms such as pruritis, watery ear discharge, otalgia, and ear blockage which significantly impairs the patient's quality of life Therapeutic...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients with clinical diagnosis of otomycosis via otoscopy
  • Exclusion Criteria:
  • Active CSOM
  • External auditory canal abnormalities
  • Patients on hearing aids

About Rawalpindi Medical College

Rawalpindi Medical College is a prestigious medical institution dedicated to advancing healthcare through rigorous clinical research and education. With a commitment to improving patient outcomes, the college actively sponsors clinical trials that explore innovative therapeutic approaches and enhance medical knowledge across various disciplines. Its team of experienced researchers and clinicians collaborates with national and international partners to ensure the highest standards of research integrity and ethical compliance. By fostering an environment of inquiry and excellence, Rawalpindi Medical College aims to contribute significantly to the field of medicine and the well-being of the community it serves.

Locations

Rawalpindi, , Pakistan

Rawalpindi, , Pakistan

Patients applied

0 patients applied

Trial Officials

Zuneera Shabbir PGR, MBBS

Principal Investigator

Rawalpindi Medical College

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported